{
    "2018-01-05": [
        [
            {
                "time": "2018-01-08",
                "original_text": "白云山拟控股广州医药8日复牌",
                "features": {
                    "keywords": [
                        "白云山",
                        "广州医药",
                        "控股",
                        "复牌"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "1月5日晚重要停复牌",
                "features": {
                    "keywords": [
                        "停复牌"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "白云山：拟10.94亿收购广州医药30%股权 下周一复牌",
                "features": {
                    "keywords": [
                        "白云山",
                        "广州医药",
                        "收购",
                        "股权",
                        "复牌"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "白云山：1月8日复牌，拟购联合美华所持广州医药30%股权",
                "features": {
                    "keywords": [
                        "白云山",
                        "广州医药",
                        "复牌",
                        "股权",
                        "联合美华"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "原创药研发寥寥无几，“限抗”下抗生素行业陷“囚徒困境”",
                "features": {
                    "keywords": [
                        "原创药",
                        "研发",
                        "限抗",
                        "抗生素",
                        "囚徒困境"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "医药港股2018年投资策略：强者恒强-掘金最具创新优势和长线价值的医药港股",
                "features": {
                    "keywords": [
                        "医药港股",
                        "投资策略",
                        "创新优势",
                        "长线价值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "晨会聚焦180105：重点关注中青旅、中际旭创、宇通客车、木林森",
                "features": {
                    "keywords": [
                        "晨会聚焦",
                        "中青旅",
                        "中际旭创",
                        "宇通客车",
                        "木林森"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "旅游",
                        "科技",
                        "汽车",
                        "LED"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}